(Q54268471)

English

Cabergoline in the long-term therapy of hyperprolactinemic disorders.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

title

Cabergoline in the long-term therapy of hyperprolactinemic disorders. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

author name string

C Ferrari

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

A Paracchi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

A M Mattei

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

S de Vincentiis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

A D'Alberton

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

P Crosignani

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

publication date

1 June 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

published in

Acta Endocrinologica

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

volume

126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

page(s)

489-494

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

Identifiers

DOI

10.1530/ACTA.0.1260489

0 references

PubMed publication ID

1642081

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1642081

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/1642081

(Q54268471)

Cabergoline in the long-term therapy of hyperprolactinemic disorders.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)